The butyrate story: Old wine in new bottles?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 7, Issue 5, 2004, Pages 563-567

  Scheppach, Wolfgang ^a   Weiler, Frank ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Butyrate; Colonic barrier; Colorectal cancer; Dietary fibre; Low digestible carbohydrates; Prebiotics; Short chain fatty acids; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; BUTYRIC ACID; CELECOXIB; FRUCTOSE OLIGOSACCHARIDE; MESALAZINE; ANTINEOPLASTIC AGENT; BUTYRIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CLINICAL TRIAL; COLON FLORA; COLON MUCOSA; COLON TUMOR; DNA MICROARRAY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; HUMAN; INTESTINE CANCER; MICROBIAL ACTIVITY; NONHUMAN; REVIEW; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM; ANIMAL; CELL TRANSFORMATION; COLON; COLORECTAL TUMOR; CYTOLOGY; DIETARY FIBER; METABOLISM; MICROBIOLOGY; PATHOLOGY; RESEARCH;

ANIMALIA; BACTERIA (MICROORGANISMS);

ANIMALS; ANTICARCINOGENIC AGENTS; BUTYRATES; CELL TRANSFORMATION, NEOPLASTIC; CLINICAL TRIALS; COLON; COLORECTAL NEOPLASMS; DIETARY FIBER; HUMANS; INFLAMMATORY BOWEL DISEASES; RESEARCH;

EID: 14844317611     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200409000-00009     Document Type: Review

References (27)

1. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361:1496-1501. In a large sample population of 520 000 the EPIC investigators show an inverse association between fibre intake and colorectal cancer risk. The discrepancy between EPIC and the (negative) US Nurses' Health Study may be explained by the greater range of fibre intake in the European trial.
2. Tsukahara T, Iwasaki Y, Nakayama K, et al. Stimulation of butyrate production in the large intestine of weaning piglets by dietary fructooligosaccharides and its influence on the histological variables of the large intestinal mucosa. J Nutr Sci Vitaminol 2003; 49:414-421.
3. Annison G, Illman RJ, Topping DL. Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J Nutr 2003; 133:3523-3528. This study in experimental animals shows ways in which the delivery of butyrate to the colon can be increased.
4. Hold GL, Schwiertz A, Aminov RI, et al. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 2003; 69:4320-4324. The identification of bacterial strains by analysis of the 16S subunit of ribosomal RNA allows the characterization of the microflora and modifying effects of pre and probiotics.
5. Schauber J, Svanholm C, Termén S, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003; 52:735-741. In addition to α and β-defensins, the cathelicidin peptide LL-37 is a factor of the innate immune system of the gut and is modulated by butyrate.
6. Klampfer L, Huang J, Sasazuki T, et al. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol Cancer Res 2003; 1:855-862.
7. Forest V, Pierre F, Bassonga E, et al. Apc+/Min colonic epithelial cells express TNF receptors and ICAM-1 when co-cultured with large intestine intra-epithelial lymphocytes. Cell Immunol 2003; 223:70-76. This co-culture model is a valuable tool to study the cross-talk between cell types.
8. Ogawa H, Rafiee P, Fisher PJ, et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun 2003; 309:512-519.
9. Venkatraman A, Ramakrishna BS, Shaji RV, et al. Amelioration of dextran sulphate colitis by butyrate: role of heat shock protein 70 and NF-κB. Am J Physiol Gastrointest Liver Physiol 2003; 285:G177-G184.
10. Moreau NM, Martin LJ, Toquet CS, et al. Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo- oligosaccharides, in dextran sulphate sodium-induced experimental colitis. Br J Nutr 2003; 90:75-85.
11. Kanauchi O, Serizawa I, Araki Y, et al. Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol 2003; 38:200-201.
12. Hallert C, Bjorck I, Nyman M, et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9:116-121.
13. Vernia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003; 33:244-248. This is one of the few controlled studies in which butyrate was tested in humans. Butyrate was found to show some benefit in active ulcerative colitis.
14. Mentschel J, Claus R. Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment. Metabolism 2003; 52:1400-1405.
15. Ebert MN, Klinder A, Peters WHM, et al. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 2003; 24:1637-1644.
16. Beyer-Sehlmeyer G, Glei M, Hartmann E, et al. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br J Nutr 2003; 90:1057-1070.
17. Buecher B, Thouminot C, Menanteau J, et al. Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of rats. Reprod Nutr Dev 2003; 43:347-356.
18. Menzel T, Melcher R, Koehler S, et al. Establishment of a colonic adenoma cell line (GeKi-2): spectral karyotype analysis and functional characterization. Int J Colorectal Dis 2004; 19:12-17. The investigators tested butyrate in a primary adenoma cell line, that is at an intermediate stage of carcinogenesis.
19. WAF1/CIP1 protein in human colonic adenocarcinoma cells independently of p53 status. Nutr Cancer 2003; 46:202-211.
20. WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int J Cancer 2004; 109:207-213.
21. Rouet-Benzineb P, Aparicio T, Guilmeau S, et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappa-B signaling. J Biol Chem 2004; 279:16495-16502. Obesity (leading the hyperleptinaemia) is a risk factor for colorectal cancer; this study shows possible mechanisms of interaction between diet-associated factors at the cellular level.
22. Augenlicht L, Shi L, Mariadason J, et al. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. Oncogene 2003; 22:4983-4992.
23. Germann A, Dihlmann S, Hergenhahn M, et al. Expression of profiling of CC531 colon carcinoma cells reveals similar regulation of β-catenin target genes by both butyrate and aspirin. Int J Cancer 2003; 106:187-197. This study shows the potential of the cDNA array technology to test the expression of 7700 genes in a single experiment.
24. Kuefer R, Hofer MD, Altug V, et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br J Cancer 2004; 90:535-541.
25. Ogawa K, Yasamura S, Atarashi Y, et al. Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J Hepatol 2004; 40:278-284.
26. Farrow B, Rychahou P, O'Connor KL, et al. Butyrate inhibits pancreatic cancer invasion. J Gastrointest Surg 2003; 7:864-970.
27. Chopin V, Touillon RA, Jouy N, Le Bourhis X. P21(WAF1/Cip1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 2004; 23:21-29.